SCHEMBL6089174

SCHEMBL6089174

COC(=O)c1c(C)cccc1COc1cccc(OCCc2ccccn2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
KDM4E B2RXH2 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
PPARG P37231 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
MAPT P10636 2/20 0.41
GAA P10253 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.40
ABCB1 P08183 1/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40
KCNA5 P22460 1/20 0.39
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SPHK2 Q9NRA0 1/20 0.39
SPHK1 Q9NYA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6088689 0.91 NPC1 (0.46) NPC1RAB9AKDM4ETDP1MAPT
SCHEMBL6090266 0.89 SLC26A4 (0.46) NPC1RAB9AKDM4ETDP1PPARG
SCHEMBL6091090 0.85 PPARG (0.42) TDP1PPARGSIRT2MAPTCYSLTR1
SCHEMBL6088001 0.84 CYSLTR1 (0.59) CYSLTR1
SCHEMBL6087884 0.83 ABCB1 (0.45) NPC1RAB9AKDM4EMAPTCYSLTR1
SCHEMBL6088329 0.83 MAOB (0.52) NPC1RAB9ATDP1MAPTCYSLTR1
SCHEMBL6088500 0.81 PTGDR2 (0.46) NPC1RAB9AKDM4ETDP1PPARG
SCHEMBL6089761 0.80 GPR132 (0.49) NPC1RAB9AKDM4ETDP1PPARG
SCHEMBL6088473 0.79 HIF1A (0.57) KDM4EALDH1A1SPHK2SPHK1
SCHEMBL6090155 0.78 NR4A2 (0.57) NPC1RAB9AKDM4ETDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed